MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx, Inc., a sponsor at the International HPV meeting this week in Montreal, Canada, announces that two presentations at the meeting demonstrated that IncellDx’s HPV OncoTect® E6/E7 mRNA kit greatly increases specificity compared to other HPV tests and was successfully used in a large clinical trial in women under 30 years of age.
